RIGEL PHARMACEUTICALS INC (RIGL) Operating income 2016–2025
RIGEL PHARMACEUTICALS INC (RIGL) annual operating income history from SEC filings — each fiscal year as reported.
$125.5MFY2025 · since FY2016: -$69.7M → $125.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $125.5M | +418.6% |
| FY2024 | $24.2M | +218.1% |
| FY2023 | -$20.5M | +63.1% |
| FY2022 | -$55.5M | -344.5% |
| FY2021 | -$12.5M | +56.9% |
| FY2020 | -$29.0M | +58.1% |
| FY2019 | -$69.1M | +4.9% |
| FY2018 | -$72.7M | +8.7% |
| FY2017 | -$79.6M | -14.2% |
| FY2016 | -$69.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice